-
Select a Community
- MB 1 Preclinical Medical Students
- MB 2/3 Clinical Medical Students
- ORTHO Orthopaedic Surgery
-
About Bullet Health
Please confirm topic selection
Are you sure you want to trigger topic in your Anconeus AI algorithm?
Please confirm action
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
Search Questions
Subspeciality
All
All (none selected)
Anatomy
Biochemistry
Embryology
Immunology
Microbiology
Pathology
Pharmacology
Reproductive
Stats
Cardiovascular
Endocrine
Gastrointestinal
Hematology
Neurology
Oncology
Renal
Respiratory
Dermatology
MSK
Psychiatry
Rest & Reinforce
General
Importance
All
All (none selected)
A - Critical
B - Essential
C - Core
D - Tested
E - Community
Complexity
All
All (none selected)
M 1
M 2
M 3
M 4
N/A
| # | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
|---|---|---|---|---|---|---|
| 301 | M1.IM.17.4767 | 109089 |
Immunology
|
Hypersensitivity |
M 2
|
C
|
| 302 | M1.IM.17.4774 | 109123 |
Immunology
|
Immunization |
M 3
|
C
|
| 303 | M1.IM.17.4799 | 109190 |
Immunology
|
Immunosuppressive Drugs |
M 1
|
C
|
| 304 | M1.IM.17.4799 | 109191 |
Immunology
|
Immunosuppressive Drugs |
M 4
|
C
|
| 305 | M1.IM.17.4798 | 109226 |
Immunology
|
Chronic Granulomatous Disease |
M 1
|
C
|
| 306 | M1.IM.17.4799 | 109306 |
Immunology
|
Innate Immune Response |
M 1
|
C
|
| 307 | M1.IM.17.4817 | 109393 |
Immunology
|
Transplant |
M 1
|
C
|
| 308 | M1.IM.17.4817 | 109403 |
Immunology
|
Hyper IgM Syndrome |
M 1
|
C
|
| 309 | M1.IM.17.4822 | 109421 |
Immunology
|
Complement |
M 1
|
C
|
| 310 | M1.IM.17.4822 | 109422 |
Immunology
|
T-Cell Activation |
M 1
|
C
|
| 311 | M1.IM.17.4867 | 109601 |
Immunology
|
Bruton Agammaglobulinemia |
M 1
|
C
|
| 312 | M1.IM.17.4867 | 109623 |
Immunology
|
Cells of the Immune System |
M 1
|
C
|
| 313 | M1.IM.17.4867 | 109627 |
Immunology
|
Antibodies |
M 1
|
C
|
| 314 | M1.IM.17.4867 | 109662 |
Immunology
|
Antibodies |
M 1
|
C
|
| 315 | M1.IM.17.4867 | 109669 |
Immunology
|
Secondary Lymphoid Tissue |
M 1
|
C
|
| 316 | M1.IM.17.4868 | 109729 |
Immunology
|
Cell-Mediated Immunity |
M 1
|
C
|
| 317 | M1.IM.17.4869 | 109746 |
Immunology
|
Hypersensitivity |
M 2
|
C
|
| 318 | M1.IM.17.4869 | 109759 |
Immunology
|
Primary Lymphoid Tissue |
M 2
|
C
|
| 319 | M1.IM.17.4868 | 109803 |
Immunology
|
Antibodies |
M 1
|
C
|
| 320 | M1.IM.17.4868 | 109808 |
Immunology
|
Chediak-Higashi Syndrome |
M 1
|
C
|
| 321 | M1.IM.17.4873 | 109975 |
Immunology
|
Immunosuppressive Drugs |
M 3
|
C
|
| 322 | M1.PA.17.4751 | 108790 |
Pathology
|
Psammoma Bodies |
M 2
|
C
|
| 323 | M1.PA.17.4754 | 108967 |
Pathology
|
Leukocyte Extravasation |
M 1
|
C
|
| 324 | M1.PA.17.4798 | 109227 |
Pathology
|
Cell Injury |
M 1
|
C
|
| 325 | M1.MC.17.4867 | 109645 |
Microbiology
|
Chloramphenicol |
M 1
|
C
|
| 326 | M1.MC.17.4868 | 109713 |
Microbiology
|
Bacillus anthracis |
M 2
|
C
|
| 327 | M1.MC.17.4868 | 109715 |
Microbiology
|
Norovirus |
M 2
|
C
|
| 328 | M1.MC.17.4868 | 109726 |
Microbiology
|
Staphylococcus aureus |
M 1
|
C
|
| 329 | M1.MC.17.4869 | 109743 |
Microbiology
|
Yersinia pestis |
M 1
|
C
|
| 330 | M1.MC.17.4871 | 109837 |
Microbiology
|
Nocardia |
M 3
|
C
|
| 331 | M1.MC.17.4872 | 109912 |
Microbiology
|
Roundworms (Nematodes) |
M 3
|
C
|
| 332 | M1.MC.17.4872 | 109968 |
Microbiology
|
Roundworms (Nematodes) |
M 2
|
C
|
| 333 | M1.MC.17.4873 | 109972 |
Microbiology
|
Clostridium perfringens |
M 2
|
C
|
| 334 | M1.MC.17.4884 | 110010 |
Microbiology
|
Chlamydia trachomatis |
M 3
|
C
|
| 335 | M1.IM.17.4707 | 108432 |
Immunology
|
Wiskott-Aldrich Syndrome |
M 2
|
C
|
| 336 | M1.PA.17.4867 | 109598 |
Pathology
|
Inflammation |
M 1
|
C
|
| 337 | M1.PA.17.4867 | 109641 |
Pathology
|
Transudate vs. Exudate |
M 1
|
C
|
| 338 | M1.PA.17.4867 | 109660 |
Pathology
|
Necrosis |
M 1
|
C
|
| 339 | M1.PA.17.4868 | 109709 |
Pathology
|
Apoptosis |
M 1
|
C
|
| 340 | M1.PA.17.4870 | 109775 |
Pathology
|
Amyloidosis |
M 1
|
C
|
| 341 | M1.PA.17.4872 | 109917 |
Pathology
|
Psammoma Bodies |
M 2
|
C
|
| 342 | M1.IM.17.4731 | 108596 |
Immunology
|
Wiskott-Aldrich Syndrome |
M 3
|
C
|
| 343 | M1.IM.17.4753 | 108888 |
Immunology
|
Cells of the Immune System |
M 1
|
C
|
| 344 | M1.PH.17.4697 | 108165 |
Pharmacology
|
Poisons and Treatments |
M 3
|
C
|
| 345 | M1.PH.17.4698 | 108187 |
Pharmacology
|
Poisons and Treatments |
M 3
|
C
|
| 346 | M1.PH.17.4698 | 108191 |
Pharmacology
|
Drug Excretion |
M 1
|
C
|
| 347 | M1.PH.17.4698 | 108196 |
Pharmacology
|
Sympathomimetics |
M 3
|
C
|
| 348 | M1.PH.17.4707 | 108437 |
Pharmacology
|
Drug Reactions and Side Effects |
M 3
|
C
|
| 349 | M1.PH.17.4722 | 108519 |
Pharmacology
|
Poisons and Treatments |
M 3
|
C
|
| 350 | M1.PH.17.4751 | 108797 |
Pharmacology
|
Beta-Blockers |
M 3
|
C
|
| 351 | M1.PH.17.4752 | 108799 |
Pharmacology
|
Alpha-Blockers |
M 3
|
C
|
| 352 | M1.PH.17.4756 | 108922 |
Pharmacology
|
Cholinomimetic Agents |
M 3
|
C
|
| 353 | M1.PH.17.4754 | 108966 |
Pharmacology
|
Sympathomimetics |
M 1
|
C
|
| 354 | M1.PH.17.4766 | 109085 |
Pharmacology
|
Drug Interactions |
M 1
|
C
|
| 355 | M1.PH.17.4767 | 109086 |
Pharmacology
|
Muscarinic Antagonists |
M 3
|
C
|
| 356 | M1.PH.17.4767 | 109087 |
Pharmacology
|
Poisons and Treatments |
M 3
|
C
|
| 357 | M1.PH.17.4798 | 109228 |
Pharmacology
|
Poisons and Treatments |
M 2
|
C
|
| 358 | M1.PH.17.4799 | 109312 |
Pharmacology
|
Enzyme Kinetics |
M 1
|
C
|
| 359 | M1.PH.17.4799 | 109313 |
Pharmacology
|
Therapeutic Index |
M 1
|
C
|
| 360 | M1.PH.17.4799 | 109315 |
Pharmacology
|
Drug Reactions and Side Effects |
M 2
|
C
|
| 361 | M1.PH.17.4799 | 109316 |
Pharmacology
|
Sympathomimetics |
M 4
|
C
|
| 362 | M1.PH.17.4799 | 109355 |
Pharmacology
|
Drug Reactions and Side Effects |
M 3
|
C
|
| 363 | M1.PH.17.4817 | 109407 |
Pharmacology
|
G Protein-Coupled Receptors (GPCR) |
M 3
|
C
|
| 364 | M1.PH.17.4817 | 109408 |
Pharmacology
|
Drug Reactions and Side Effects |
M 1
|
C
|
| 365 | M1.PH.17.4867 | 109628 |
Pharmacology
|
Pharmacokinetics |
M 1
|
C
|
| 366 | M1.PH.17.4867 | 109663 |
Pharmacology
|
Elimination of Drugs |
M 1
|
C
|
| 367 | M1.PH.17.4869 | 109755 |
Pharmacology
|
Therapeutic Index |
M 1
|
C
|
| 368 | M1.PH.17.4870 | 109824 |
Pharmacology
|
Poisons and Treatments |
M 3
|
C
|
| 369 | M1.PH.17.4870 | 109857 |
Pharmacology
|
Autonomic Pathways |
M 3
|
C
|
| 370 | M1.CV.17.4694 | 107904 |
Cardiovascular
|
Coronary Artery Anatomy |
M 2
|
C
|
| 371 | M1.CV.17.4695 | 107936 |
Cardiovascular
|
Cardiac Output and Variables |
M 1
|
C
|
| 372 | M1.CV.17.4695 | 107968 |
Cardiovascular
|
Cardiac Output and Variables |
M 1
|
C
|
| 373 | M1.CV.17.4695 | 107996 |
Cardiovascular
|
Lipid Lowering Drugs |
M 1
|
C
|
| 374 | M1.CV.17.4697 | 108146 |
Cardiovascular
|
Atrioventricular (AV) Heart Block |
M 2
|
C
|
| 375 | M1.CV.17.4754 | 108868 |
Cardiovascular
|
Pericarditis |
M 2
|
C
|
| 376 | M1.CV.17.4754 | 108870 |
Cardiovascular
|
Tetralogy of Fallot |
M 1
|
C
|
| 377 | M1.CV.17.4754 | 108871 |
Cardiovascular
|
Cardiomyopathies |
M 1
|
C
|
| 378 | M1.CV.17.4754 | 108872 |
Cardiovascular
|
Aortic Dissection |
M 4
|
C
|
| 379 | M1.CV.17.4754 | 108873 |
Cardiovascular
|
Atrioventricular (AV) Heart Block |
M 2
|
C
|
| 380 | M1.CV.17.4755 | 108876 |
Cardiovascular
|
Torsades de Pointes |
M 3
|
C
|
| 381 | M1.CV.17.4755 | 108877 |
Cardiovascular
|
Cardiac Glycosides (Digoxin) |
M 3
|
C
|
| 382 | M1.CV.17.4764 | 109028 |
Cardiovascular
|
Angina |
M 1
|
C
|
| 383 | M1.CV.17.4764 | 109029 |
Cardiovascular
|
Resistance, Pressure, and Flow |
M 1
|
C
|
| 384 | M1.CV.17.4765 | 109033 |
Cardiovascular
|
Baroreceptors and Chemoreceptors |
M 3
|
C
|
| 385 | M1.CV.17.4765 | 109034 |
Cardiovascular
|
Starling Curve |
M 1
|
C
|
| 386 | M1.CV.17.4766 | 109036 |
Cardiovascular
|
Cardiac / Vascular Function Curves |
M 1
|
C
|
| 387 | M1.CV.17.4765 | 109037 |
Cardiovascular
|
Cardiac Cycle |
M 2
|
C
|
| 388 | M1.CV.17.4765 | 109040 |
Cardiovascular
|
Splitting |
M 2
|
C
|
| 389 | M1.CV.17.4798 | 109209 |
Cardiovascular
|
Antiarrhythmics |
M 1
|
C
|
| 390 | M1.CV.17.4798 | 109221 |
Cardiovascular
|
Antiarrhythmics |
M 3
|
C
|
| 391 | M1.CV.17.4699 | 108371 |
Cardiovascular
|
Abdominal Aortic Aneurysm |
M 2
|
C
|
| 392 | M1.CV.17.4707 | 108428 |
Cardiovascular
|
Coarctation of the Aorta |
M 2
|
C
|
| 393 | M1.CV.17.4719 | 108508 |
Cardiovascular
|
Large Vessel Vasculitides |
M 3
|
C
|
| 394 | M1.CV.17.4723 | 108549 |
Cardiovascular
|
Coronary Artery Anatomy |
M 2
|
C
|
| 395 | M1.CV.17.4726 | 108574 |
Cardiovascular
|
Cardiac Output and Variables |
M 1
|
C
|
| 396 | M1.CV.17.4726 | 108576 |
Cardiovascular
|
Valvular Disease |
M 2
|
C
|
| 397 | M1.CV.17.4732 | 108620 |
Cardiovascular
|
Small Vessel Vasculitides with Immune Complexes |
M 2
|
C
|
| 398 | M1.CV.17.4754 | 108701 |
Cardiovascular
|
Congestive Heart Failure |
M 1
|
C
|
| 399 | M1.CV.17.4754 | 108713 |
Cardiovascular
|
Valvular Disease |
M 2
|
C
|
| 400 | M1.CV.17.4753 | 108857 |
Cardiovascular
|
Cardiac Output and Variables |
M 3
|
C
|
| 401 | M1.CV.17.4753 | 108858 |
Cardiovascular
|
Antianginal Therapy |
M 4
|
C
|
| 402 | M1.CV.17.4754 | 108862 |
Cardiovascular
|
Lipid Lowering Drugs |
M 4
|
C
|
| 403 | M1.CV.17.4753 | 108864 |
Cardiovascular
|
Antihypertensive Therapy |
M 4
|
C
|
| 404 | M1.CV.17.4698 | 108177 |
Cardiovascular
|
Antiarrhythmics |
M 3
|
C
|
| 405 | M1.CV.17.4698 | 108179 |
Cardiovascular
|
Direct-Acting Vasodilators |
M 3
|
C
|
| 406 | M1.CV.17.4698 | 108253 |
Cardiovascular
|
Medium Vessel Vasculitides |
M 2
|
C
|
| 407 | M1.CV.17.4867 | 109586 |
Cardiovascular
|
SA Node Action Potential |
M 1
|
C
|
| 408 | M1.CV.17.4867 | 109657 |
Cardiovascular
|
Myocardial Infarction |
M 4
|
C
|
| 409 | M1.CV.17.4868 | 109733 |
Cardiovascular
|
Transposition of Great Vessels |
M 3
|
C
|
| 410 | M1.CV.17.4869 | 109766 |
Cardiovascular
|
Cardiac Tamponade |
M 2
|
C
|
| 411 | M1.CV.17.4871 | 109847 |
Cardiovascular
|
Arteriosclerosis |
M 1
|
C
|
| 412 | M1.CV.17.4869 | 109862 |
Cardiovascular
|
Electrocardiogram (ECG) |
M 2
|
C
|
| 413 | M1.EC.17.4695 | 107917 |
Endocrine
|
Thyroglossal Duct Cyst |
M 1
|
C
|
| 414 | M1.EC.17.4695 | 107928 |
Endocrine
|
Growth Hormone Adenoma / Acromegaly |
M 2
|
C
|
| 415 | M1.EC.17.4695 | 107947 |
Endocrine
|
Insulin and Glucagon |
M 1
|
C
|
| 416 | M1.EC.17.4698 | 108199 |
Endocrine
|
Diabetes Drugs |
M 3
|
C
|
| 417 | M1.EC.17.4698 | 108200 |
Endocrine
|
Diabetes Drugs |
M 3
|
C
|
| 418 | M1.EC.17.4713 | 108484 |
Endocrine
|
Graves Disease |
M 1
|
C
|
| 419 | M1.EC.17.4713 | 108485 |
Endocrine
|
Pheochromocytoma |
M 3
|
C
|
| 420 | M1.EC.17.4720 | 108512 |
Endocrine
|
Growth Hormone Adenoma / Acromegaly |
M 2
|
C
|
| 421 | M1.EC.17.4751 | 108781 |
Endocrine
|
Hyperparathyroidism |
M 2
|
C
|
| 422 | M1.EC.17.4753 | 108838 |
Endocrine
|
Hypothyroidism vs Hyperthyroidism |
M 1
|
C
|
| 423 | M1.EC.17.4753 | 108839 |
Endocrine
|
Growth Hormone Adenoma / Acromegaly |
M 2
|
C
|
| 424 | M1.EC.17.4753 | 108840 |
Endocrine
|
Hashimoto Thyroiditis |
M 1
|
C
|
| 425 | M1.EC.17.4753 | 108842 |
Endocrine
|
Multiple Endocrine Neoplasias |
M 2
|
C
|
| 426 | M1.EC.17.4765 | 109030 |
Endocrine
|
Endocrine Pancreas |
M 1
|
C
|
| 427 | M1.EC.17.4768 | 109062 |
Endocrine
|
Craniopharyngioma |
M 2
|
C
|
| 428 | M1.EC.17.4798 | 109211 |
Endocrine
|
Hyperparathyroidism |
M 3
|
C
|
| 429 | M1.EC.17.4800 | 109276 |
Endocrine
|
Diabetes Mellitus |
M 3
|
C
|
| 430 | M1.EC.17.4800 | 109280 |
Endocrine
|
Syndrome of Inappropriate ADH (SIADH) |
M 2
|
C
|
| 431 | M1.EC.17.4799 | 109304 |
Endocrine
|
Pituitary (Hypophysis) |
M 1
|
C
|
| 432 | M1.EC.17.4799 | 109305 |
Endocrine
|
Diabetes Drugs |
M 3
|
C
|
| 433 | M1.EC.17.4799 | 109331 |
Endocrine
|
Hypothalamic / Pituitary Drugs |
M 4
|
C
|
| 434 | M1.EC.17.4800 | 109333 |
Endocrine
|
Diabetes Drugs |
M 4
|
C
|
| 435 | M1.EC.17.4817 | 109400 |
Endocrine
|
Diabetes Insipidus |
M 1
|
C
|
| 436 | M1.EC.17.4817 | 109401 |
Endocrine
|
Diabetes Mellitus |
M 1
|
C
|
| 437 | M1.EC.17.4817 | 109402 |
Endocrine
|
Diabetic Ketoacidosis (DKA) |
M 2
|
C
|
| 438 | M1.CV.17.4867 | 109638 |
Cardiovascular
|
Electrocardiogram (ECG) |
M 1
|
C
|
| 439 | M1.EC.17.4751 | 108723 |
Endocrine
|
Adrenogenital Syndrome (Congenital Adrenal Hyperplasia) |
M 1
|
C
|
| 440 | M1.EC.17.4750 | 108777 |
Endocrine
|
Vitamin D |
M 1
|
C
|
| 441 | M1.EC.17.4868 | 109712 |
Endocrine
|
Thyroid Hormones |
M 1
|
C
|
| 442 | M1.EC.17.4868 | 109735 |
Endocrine
|
Multiple Endocrine Neoplasias |
M 1
|
C
|
| 443 | M1.EC.17.4868 | 109738 |
Endocrine
|
Hyperaldosteronism / Conn Syndrome |
M 3
|
C
|
| 444 | M1.EC.17.4869 | 109767 |
Endocrine
|
Thyroid Drugs |
M 1
|
C
|
| 445 | M1.EC.17.4867 | 109634 |
Endocrine
|
Insulin and Glucagon |
M 3
|
C
|
| 446 | M1.EC.17.4873 | 109973 |
Endocrine
|
Subacute Thyroiditis (de Quervain) |
M 2
|
C
|
| 447 | M1.GI.17.75 | 106786 |
Gastrointestinal
|
Hemochromatosis |
M 1
|
C
|
| 448 | M1.GI.17.4694 | 107886 |
Gastrointestinal
|
Celiac Trunk |
M 1
|
C
|
| 449 | M1.GI.17.4707 | 108457 |
Gastrointestinal
|
Wilson Disease |
M 2
|
C
|
| 450 | M1.GI.17.4717 | 108493 |
Gastrointestinal
|
Crigler-Najjar Syndrome |
M 1
|
C
|